• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Treatment selection factors for stereotactic radiosurgery of intracranial metastases.

作者信息

Buatti J M, Friedman W A, Bova F J, Mendenhall W M

机构信息

Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, USA.

出版信息

Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):1161-6. doi: 10.1016/0360-3016(94)00461-s.

DOI:10.1016/0360-3016(94)00461-s
PMID:7607938
Abstract

PURPOSE

To define treatment selection criteria for patients with intracranial metastases treated with stereotactic radiosurgery.

METHODS AND MATERIALS

Between August 1989 and July 1993, 25 patients with intracranial metastases (28 lesions) were treated with stereotactic radiosurgery at the University of Florida. Thirteen patients were treated for progressive intracranial disease after external-beam radiotherapy, and 12 were treated with radiosurgery as an adjunct to initial treatment. Minimum eligibility criteria included histologic verification of primary disease, Karnofsky performance status 50% or greater, three or fewer intracranial metastases, radiographically distinct lesion(s) 4 cm or less in diameter, and reasonably well-controlled primary disease. Univariate and multivariate analyses tested the prognostic significance of Karnofsky performance status, lesion volume, number of lesions, treatment dose (both external beam and stereotactic), histology, site of primary disease, and time interval (less than or greater than 1 year) from primary diagnosis to development of intracranial metastasis or from treatment of intracranial disease to recurrence.

RESULTS

Local control was achieved in 84% of 28 lesions treated. The only significant prognostic indicator among the tested variables was the interval to development or recurrence of intracranial metastasis.

CONCLUSION

Although stereotactic radiosurgery improves local control rates and is likely to offer improved palliation for a select cohort of patients, the selection criteria for such patients remain poorly defined. Our data suggest that an interval of greater than 1 year from primary disease diagnosis to development of intracranial metastasis, or from treatment of intracranial metastasis to its recurrence, defines a patient cohort that is more likely to benefit from this treatment technique.

摘要

相似文献

1
Treatment selection factors for stereotactic radiosurgery of intracranial metastases.
Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):1161-6. doi: 10.1016/0360-3016(94)00461-s.
2
Analysis of prognostic factors for patients with single brain metastasis treated with stereotactic radiosurgery.立体定向放射外科治疗单发性脑转移瘤患者的预后因素分析。
Radiat Oncol Investig. 1997;5(1):31-7. doi: 10.1002/(SICI)1520-6823(1997)5:1<31::AID-ROI5>3.0.CO;2-L.
3
Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.多发颅内转移患者手术后和立体定向放射外科治疗后的生存:一项单中心回顾性研究的结果。
J Neurosurg. 2014 Oct;121(4):839-45. doi: 10.3171/2014.4.JNS13789. Epub 2014 May 23.
4
Stereotactic radiosurgery for the treatment of brain metastases. Results of a single institution series.立体定向放射外科治疗脑转移瘤。单机构系列研究结果。
Cancer. 1997 Feb 1;79(3):551-7. doi: 10.1002/(sici)1097-0142(19970201)79:3<551::aid-cncr18>3.0.co;2-2.
5
Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.全脑放疗后行立体定向放射外科治疗复发性脑转移瘤患者的生存预后因素分析。
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):303-9. doi: 10.1016/j.ijrobp.2011.06.1987. Epub 2011 Nov 11.
6
Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.颅内转移瘤切除床的立体定向放射外科治疗与软脑膜癌病风险
J Neurosurg. 2014 Dec;121 Suppl:75-83. doi: 10.3171/2014.6.GKS14708.
7
Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.103例患者的153个脑黑色素瘤转移灶的立体定向放射外科治疗。
Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1097-106. doi: 10.1016/j.ijrobp.2003.12.037.
8
Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery.立体定向伽玛刀放射外科治疗脑转移瘤的生存情况及失败模式
J Neurosurg. 2002 Dec;97(5 Suppl):499-506. doi: 10.3171/jns.2002.97.supplement.
9
Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery.脑转移性黑色素瘤:伽玛刀放射治疗后的预后因素
Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1277-87. doi: 10.1016/s0360-3016(01)02772-9.
10
Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.早期对切除的脑转移瘤瘤床进行伽玛刀立体定向放射外科治疗以改善局部控制。
J Neurosurg. 2014 Dec;121 Suppl:69-74. doi: 10.3171/2014.7.GKS141488.

引用本文的文献

1
Gamma knife radiosurgery for metastatic brain tumors from thyroid cancer.伽玛刀放射外科治疗甲状腺癌脑转移瘤
J Neurooncol. 2009 Jul;93(3):355-9. doi: 10.1007/s11060-008-9783-2. Epub 2009 Jan 13.
2
Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease.经过恰当挑选的多发性脑转移患者可能会从积极治疗其颅内疾病中获益。
J Neurooncol. 2003 Jan;61(1):73-80. doi: 10.1023/a:1021262218151.
3
Brain metastases: treatment options to improve outcomes.脑转移瘤:改善治疗结果的选择
CNS Drugs. 2002;16(5):325-38. doi: 10.2165/00023210-200216050-00005.
4
Patient selection criteria for the treatment of brain metastases with stereotactic radiosurgery.立体定向放射外科治疗脑转移瘤的患者选择标准。
J Neurooncol. 1998 Oct;40(1):73-86. doi: 10.1023/a:1006169109920.
5
Stereotactic radiosurgery for brain metastases: comparison of lung carcinoma vs. non-lung tumors.立体定向放射外科治疗脑转移瘤:肺癌与非肺部肿瘤的比较
J Neurooncol. 1998 Mar;37(1):79-85. doi: 10.1023/a:1005958215384.